RAD51 and endometrial carcinoma: Similarly, a study in high-grade endometrial carcinomas reported that TP53 variants were more often present in HRD tumors than HR-proficient ones (100% vs. 41%; p = 0.019) but the HR status was determined by the quantification of RAD51-containing ionizing radiation-induced foci [28].